NCT00006473
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +57 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,970 public trials
2,024 recruiting studies
Immunoproliferative Disorders trial results
NCT00084916
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +44 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00005064
- Conditions
- Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +34 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00087204
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +45 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01774162
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +20 more
- Locations
-
- Royal Alexandria Hospital Edmonton, Alberta, Canada
- University of Alberta Hospital Edmonton, Alberta, Canada
NCT00006213
- Conditions
- Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +37 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00005805
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00008359
- Conditions
- Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00004245
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia
NCT00777738
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hopital La Pitie Salpetriere Paris, France